Ranbaxy halts generic Lipitor production in US
Press Trust of India : New Delhi, Sat Dec 01 2012, 01:42 hrs
Related
Top Stories
- Rs 20L seized from Ajit Chandila relative's home, another ex-cricketer held
- India and China ask SRs to work on more border steps
- Can't charge man with rape over consensual sex even if marriage eludes: Supreme Court
- Saudi Arabian authorities refuse to accept new Indian passports
- FIR filed against Facebook for not discontinuing hate page
Ranbaxy Laboratories has stopped production of its generic version of cholesterol lowering drug Lipitor until it investigates the issue of potential glass particles in certain lots, the US health regulator has said.
The Indian drug major on November 9 had informed its customers of a voluntary recall of certain lots of the company's 10mg, 20mg, and 40mg dosage strengths of atorvastatin tablets (generic version of Lipitor), the US Food and Drug Administration (USFDA) said in a statement.
Please read our terms of use before posting comments
After lull, highway projects see aggressive bid offers
PM: Govt initiating more measures to attract investments
Cautious RBI cuts repo by 25 bps, says little space for more easing
‘Govt mulling stronger laws to block Ponzi schemes’
TERMS OF USE: The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).
Editors’ Pick
- Former Ranji player among 3 more held
- Rajasthan Royals to file FIR against tainted trio
- If found guilty, BCCI to ask ICC to erase Sreesanth records
- Top cops among 42 named in death of blast accused
- Manmohan-Li talks: PM takes tough line on incursion issue
- Security forces blame Maoists, villagers say CoBRA man was killed in 'friendly fire'
- Travellers’ nightmare: Yellow fever vaccine stocks run out, production unit awaits repair
